FUNCTIONAL-ANALYSIS OF NOVEL SELECTIVE MUTANTS OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

被引:0
|
作者
HIZI, A
SHAHARABANY, M
机构
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have generated by site-directed mutagenesis plasmids that induce the synthesis of specific mutants of the reverse transcriptase (RT) of human immunodeficiency virus type 1 (HIV-1). These recombinant mutants of HIV-1 RT, designed on the basis of our previous studies of HIV-1 and HIV-2 RTs, were analyzed for structure-function relationship by assessing their RNA-dependent and DNA-dependent DNA polymerase as well as the ribonuclease H activities. Three groups of mutants were studied. 1) We have investigated the importance of the only two sets of highly conserved double prolines found in the sequence of HIV-1 RT. The results indicate that the conversion of either one or both prolines (at positions 225 and 226) to threonines have no significant effect on all catalytic activities of the enzyme. The mutants in which prolines 419 and 420 were individually modified to threonines exhibit full activities, whereas the double proline 419/420 mutant lost most of its RNase H activity (although the DNA polymerase function was fully retained). 2) We have deleted phenylalanine 346 from HIV-1 RT, which is absent in wild type HIV-2 RT. This mutant of HIV-1 RT lost practically all catalytic activities. 3) A mutant of HIV-1 RT in which a cysteine residue substituted for alanine 446, was found to be slightly hyperactive for both DNA polymerase and RNase H activities.
引用
下载
收藏
页码:18255 / 18258
页数:4
相关论文
共 50 条
  • [31] KINETIC AND MUTATIONAL ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE INHIBITION BY INOPHYLLUMS, A NOVEL CLASS OF NONNUCLEOSIDE INHIBITORS
    TAYLOR, PB
    CULP, JS
    DEBOUCK, C
    JOHNSON, RK
    PATIL, AD
    WOOLF, DJ
    BROOKS, I
    HERTZBERG, RP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (09) : 6325 - 6331
  • [32] SELECTIVE AND SYNERGISTIC INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE BY A NONNUCLEOSIDE INHIBITOR, MKC-442
    YUASA, S
    SADAKATA, Y
    TAKASHIMA, H
    SEKIYA, K
    INOUYE, N
    UBASAWA, M
    BABA, M
    MOLECULAR PHARMACOLOGY, 1993, 44 (04) : 895 - 900
  • [33] SPECIFIC-INHIBITION OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND THE CHIMERIC ENZYMES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 BY NONNUCLEOSIDE INHIBITORS
    HIZI, A
    TAL, R
    SHAHARABANY, M
    CURRENS, MJ
    BOYD, MR
    HUGHES, SH
    MCMAHON, JB
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) : 1037 - 1042
  • [34] MUTATIONAL ANALYSIS OF THE FINGERS AND PALM SUBDOMAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REVERSE-TRANSCRIPTASE
    BOYER, PL
    FERRIS, AL
    CLARK, P
    WHITMER, J
    FRANK, P
    TANTILLO, C
    ARNOLD, E
    HUGHES, SH
    JOURNAL OF MOLECULAR BIOLOGY, 1994, 243 (03) : 472 - 483
  • [35] INFECTIOUS POTENTIAL OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 REVERSE-TRANSCRIPTASE MUTANTS WITH ALTERED INHIBITOR SENSITIVITY
    LARDER, BA
    KEMP, SD
    PURIFOY, DJM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (13) : 4803 - 4807
  • [36] NOVEL MUTATIONS IN REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REDUCE SUSCEPTIBILITY TO FOSCARNET IN LABORATORY AND CLINICAL ISOLATES
    MELLORS, JW
    BAZMI, HZ
    SCHINAZI, RF
    ROY, BM
    HSIOU, Y
    ARNOLD, E
    WEIR, J
    MAYERS, DL
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (05) : 1087 - 1092
  • [37] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE - AFFINITY LABELING OF THE PRIMER BINDING-SITE
    MITINA, RL
    DORONIN, SV
    DOBRIKOV, MI
    TABATADZE, DR
    LEVINA, AS
    LAVRIK, OI
    FEBS LETTERS, 1992, 312 (2-3) : 249 - 251
  • [38] INITIAL BINDING OF 2'-DEOXYNUCLEOSIDE 5'-TRIPHOSPHATES TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    PAINTER, GR
    WRIGHT, LL
    HOPKINS, S
    FURMAN, PA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (29) : 19362 - 19368
  • [39] STRUCTURE OF THE BINDING-SITE FOR NONNUCLEOSIDE INHIBITORS OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    SMERDON, SJ
    JAGER, J
    WANG, J
    KOHLSTAEDT, LA
    CHIRINO, AJ
    FRIEDMAN, JM
    RICE, PA
    STEITZ, TA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) : 3911 - 3915
  • [40] INTERACTIONS BETWEEN DRUG-RESISTANCE MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    LARDER, BA
    JOURNAL OF GENERAL VIROLOGY, 1994, 75 : 951 - 957